Long-Term Benefits of Composite Treatment Targe...

By HEOR Staff Writer

January 21, 2026

Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes A recent modeling study examines the lon...
Navigating Economic Resilience Through Life Sciences Investment
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
Africa Medicine Roadmap: Paving the Way for Sustainable Access to Quality Pha...
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...